Communicable Disease Surveillance: Monthly

Disease

Anaplasmosis-Anaplasma phagocytophilum

I

Feb 2023

0

17

0%

Disease

Campylobacteriosis

I

Feb 2023

1

2

0%

Disease

Chlamydia

I

Feb 2023

20

1

-49%

Disease

Coccidioidomycosis - Valley Fever

I

Feb 2023

0

5

0%

Disease

CP-CRE

I

Feb 2023

0

11

0%

Disease

Cryptosporidiosis

I

Feb 2023

1

0%

Disease

E. Coli, Shiga Toxin-Producing

I

Feb 2023

0

1

0%

Disease

Giardiasis

I

Feb 2023

0

2

0%

Disease

Gonorrhea (gonococcal infection)

I

Feb 2023

5

1

-69%

Disease

Haemophilus Influenzae (Invasive Disease)

I

Feb 2023

0

1

0%

Disease

Hepatitis A

I

Feb 2023

0

14

0%

Disease

Hepatitis B Acute

I

Feb 2023

0

21

0%

Disease

Hepatitis B-Chronic Non-Perinatal

I

Feb 2023

2

1

0%

Disease

Hepatitis B-Perinatal Infection

I

Feb 2023

0

8

0%

Disease

Hepatitis C - Acute

I

Feb 2023

0

1

0%

Disease

Hepatitis C-Perinatal Infection

I

Feb 2023

0

1

0%

Disease

Hepatitis C-Chronic Non-Perinatal

I

Feb 2023

8

2

60%

Disease

Hepatitis E

I

Feb 2023

0

18

0%

Disease

Influenza-associated hospitalization

I

Feb 2023

3

2

200%

Disease

Legionellosis

I

Feb 2023

0

6

0%

Disease

Listeriosis

I

Feb 2023

0

6

0%

Disease

Lyme Disease

I

Feb 2023

0

3

0%

Disease

Malaria

I

Feb 2023

1

0%

Disease

Measles

I

Feb 2023

0

1

0%

Disease

Meningitis-aseptic/viral

I

Feb 2023

1

2

0%

Disease

Meningitis-bacterial

I

Feb 2023

0

4

0%

Disease

MIS-C associated with COVID-19

I

Feb 2023

0

9

0%

Disease

Monkeypox

I

Feb 2023

0

2

0%

Disease

Mumps

I

Feb 2023

0

1

0%

Disease

Rabies-animal

I

Feb 2023

0

17

0%

Disease

Pertussis

I

Feb 2023

1

0%

Disease

Rocky Mountain Spotted Fever - RMSF

I

Feb 2023

0

5

0%

Disease

Salmonellosis

I

Feb 2023

2

1

100%

Disease

Shigellosis

I

Feb 2023

0

3

0%

Disease

Spotted Fever Rickettsiosis, including Rocky Mountain spotted fever (RMSF)

I

Feb 2023

0

6

0%

Disease

Staphylococcal aureus - intermediate resistance to vancomycin (VISA)

I

Feb 2023

0

13

0%

Disease

Streptococcal-Group A-Invasive

I

Feb 2023

1

0%

Disease

Streptococcus pneumoniae - invasive antibiotic resistance unknown or non-resistant

I

Feb 2023

0

3

0%

Disease

Streptococcus pneumoniae - invasive antibiotic resistant/intermediate

I

Feb 2023

0

1

0%

Disease

Syphilis

I

Feb 2023

2

1

100%

Disease

Tuberculosis

I

Feb 2023

0

13

0%

Disease

Tularemia

I

Feb 2023

0

8

0%

Disease

Varicella - Chickenpox

I

Feb 2023

0

2

0%

Disease

Vibriosis

I

Feb 2023

0

5

0%

Disease

Yersiniosis

I

Feb 2023

1

0%